The invention relates to the equine GM-CSF, its nucleotide coding sequence
and its amino acid sequence, as well as its use as adjuvant in equine
vaccination and as non-specific immunity stimulant. The invention also
includes compositions containing equine GM-CSF or vectors expressing
GM-CSF in vivo.